Kantonsspital Münsterlingen - Spital Thurgau AG

Münsterlingen, Thurgau CH8596

0 studies enrolling now · 1 studies all time

What they study most

Advanced Breast Cancer

Studies at this site

• A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer — Running, not enrolling